Create Alert
Watchlist

Senores Pharmaceuticals

₹785.55
-8.40 (1.06%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
790.70
Prev. Close
793.95
Volume
88,041
Total traded value
6.92 Cr
Upper Circuit
942.65
Lower Circuit
628.45

Fundamentals

Market Cap₹3,648Cr
ROE10.70%
P/E Ratio(TTM)42.57
EPS(TTM)18.61
P/B Ratio4.48
Dividend Yield0.00%
Industry P/E33.36
Book Value176.75
Debt to Equity0.30
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited is a healthcare company operating in regulated markets, which make up 60-70% of revenue, and in emerging markets across the globe. Its guiding vision is a commitment to global wellness, reflecting its dedication to improving health on a worldwide scale. A key part of its strategy is the ability to supply to government channels, which provides stable demand and sets it apart from many competitors. The company's entire formulation manufacturing is performed locally in the United States, supporting its business in regulated markets. The company is also strengthening its supply chain through a backward integration strategy, which is expected to drive sustainable future growth. For the upcoming financial year, the company has guided that it should achieve a total revenue of about INR 600 crores.;
Parent OrganisationSenores Pharmaceuticals
Managing DirectorSWAPNIL SHAH
Founded2017
NSE SymbolSENORES

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
45.80%
Retail And Others
41.31%
Other Domestic Institutions
5.08%
Foreign Institutions
4.28%
Mutual Funds
3.54%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
58.97
Ajanta Pharma
NA
(0.00%)
33.22
Gland Pharma
NA
(0.00%)
36.85
Eris Lifesciences
NA
(0.00%)
47.83